---
figid: PMC3069685__oncotarget-01-457-g002
figtitle: An Activating Transcription Factor 5-Mediated Survival Pathway as a Target
  for Cancer Therapy
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC3069685
filename: oncotarget-01-457-g002.jpg
figlink: /pmc/articles/PMC3069685/figure/F2/
number: F2
caption: Cell surface receptors (FGFR or EGFR) activate RAS/MAPK or PI3K signaling
  pathways through FGFR substrate 2 (FRS2) and culminate in the activation of CREB3L2,
  which in turn stimulates transcription of ATF5. ATF5 then antagonizes apoptosis
  by directly up-regulating expression of the anti-apoptotic factor MCL1. Commercially
  available pharmacological inhibitors of several components of the ATF5-mediated
  survival pathway are indicated in gray.
papertitle: An Activating Transcription Factor 5-Mediated Survival Pathway as a Target
  for Cancer Therapy.
reftext: Zhi Sheng, et al. Oncotarget. 2010 Oct;1(6):457-460.
year: '2010'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9519178
figid_alias: PMC3069685__F2
figtype: Figure
redirect_from: /figures/PMC3069685__F2
ndex: bc08864a-deea-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3069685__oncotarget-01-457-g002.html
  '@type': Dataset
  description: Cell surface receptors (FGFR or EGFR) activate RAS/MAPK or PI3K signaling
    pathways through FGFR substrate 2 (FRS2) and culminate in the activation of CREB3L2,
    which in turn stimulates transcription of ATF5. ATF5 then antagonizes apoptosis
    by directly up-regulating expression of the anti-apoptotic factor MCL1. Commercially
    available pharmacological inhibitors of several components of the ATF5-mediated
    survival pathway are indicated in gray.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - FRS2
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - KRAS
  - HRAS
  - NRAS
  - PAK1
  - PKN1
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - AKT1
  - AKT2
  - AKT3
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - CREB3L2
  - EPHB2
  - MAPK1
  - MAPK3
  - ATF5
  - MCL1
  - Manumycin A
  - LY294002
  - U0126H
  - PD173074
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
---
